Xiamen Amoytop Biotech Co., Ltd., founded in 1996, is an innovative biopharmaceutical company in China, specializing in R&D, manufacturing and marketing of regular and long-acting recombinant protein drugs. Focusing on the R&D of immune-related cytokine medicines, Amoytop Biotech is committed to becoming a leader in solving cytokine medicine-based systemic immune problems, providing better solutions for unmet medical needs, such as viral hepatitis and malignant tumors, and immunotherapy. Looking into the future, Amoytop Biotech is especially focusing on CHB (chronic hepatitis B) treatment and will keep advancing the clinical research progress of multiple ongoing pipeline programs aiming to achieve breakthroughs in the clinical cure of CHB.
Company Details
- Employees
- 99
- Founded
- -
- Address
- No. 330, Wengjiao Road, Xinyang, Haicang, Xiamen,fujian 361028,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- amoytop.com
- HQ
- Xiamen, Fujian
Amoytop Biotech Questions
Amoytop Biotech's website is amoytop.com
Amoytop Biotech's LinkedIn profile is https://cn.linkedin.com/company/amoytopbiotech
Amoytop Biotech has
99 employees.
View email and phone details for 99
employees at Amoytop Biotech.
Amoytop Biotech's industry is
Pharmaceutical Manufacturing
Amoytop Biotech's top competitors are
Wantai Biopharm,
Rheinland Klinikum Neuss Gmbh,
Wee Speak,
Xiamen Innovax Biotech Co., Ltd.,
Sanyo Chemical Laboratories Malaysia Sdn. Bhd.,
Bioengine,
Physiosport Köln,
Study At Nanjing University Of Chinese Medicine (Study At Njucm),
浙江大学医学院附属第二医院,
杭州百诚医药科技股份有限公司.
Amoytop Biotech's categories are Pharmaceutical Manufacturing
Amoytop Biotech's founding year is 1996
